|
US5885971A
(en)
*
|
1995-03-24 |
1999-03-23 |
The Regents Of The University Of California |
Gene therapy by secretory gland expression
|
|
US6531455B1
(en)
*
|
1995-03-24 |
2003-03-11 |
The Regents Of The University Of California |
Delivery of polynucleotides by secretory gland expression
|
|
US20020037867A1
(en)
*
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
CA2265460A1
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US6797505B2
(en)
*
|
1998-05-27 |
2004-09-28 |
Cell Genesys, Inc. |
Recombinant AAV vectors for gene therapy of hemophilia A
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
AU762220B2
(en)
|
1998-05-28 |
2003-06-19 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
AAV5 vector and uses thereof
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
ATE454445T1
(de)
|
1998-11-10 |
2010-01-15 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
CA2364417C
(en)
*
|
1999-02-19 |
2013-11-05 |
Matthew John During |
Peroral gene therapy of diabetes and obesity
|
|
AU5470900A
(en)
*
|
1999-06-08 |
2000-12-28 |
Children's Hospital Of Philadelphia, The |
Methods for preventing formation of inhibitory antibodies in the setting of genetherapy
|
|
US6610906B1
(en)
*
|
1999-06-09 |
2003-08-26 |
The Regents Of The University Of Michigan |
Nucleotide sequences for gene regulation and methods of use thereof
|
|
WO2001049118A1
(en)
*
|
2000-01-03 |
2001-07-12 |
Panagenic International, Inc. |
Compositions comprising genome segments and methods of using the same
|
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
|
CA2410901C
(en)
*
|
2000-06-01 |
2012-03-20 |
University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
AU2001268373A1
(en)
*
|
2000-06-13 |
2001-12-24 |
The Children's Hospital Of Philadelphia |
Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
|
|
US7125841B2
(en)
*
|
2000-11-14 |
2006-10-24 |
The University Of Texas Systems |
Mutant human factor IX with an increased resistance to inhibition by heparin
|
|
US6794376B2
(en)
*
|
2000-12-06 |
2004-09-21 |
William Beaumont Hospital |
Methods and compositions for enhancing diffusion of therapeutic agents through tissue
|
|
US20020159978A1
(en)
*
|
2001-02-06 |
2002-10-31 |
James Allen |
Muscle-directed gene transfer by use of recombinant AAV-1 and AAV-6 virions
|
|
EP1418810A4
(en)
|
2001-08-03 |
2006-08-02 |
Us Gov Health & Human Serv |
TREATMENT OF HEMOPHILIA ORAL
|
|
ES2388170T3
(es)
|
2001-08-24 |
2012-10-09 |
Uvic Industry Partnerships Inc. |
Proaerolisina que contiene secuencias de activación de proteasa y métodos de uso para el tratamiento del cáncer de próstata
|
|
US20030198620A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
US20040092008A1
(en)
*
|
2002-11-12 |
2004-05-13 |
Snyder Richard O. |
Recombinant AAV vectors for gene therapy of hemophilia A
|
|
US8927269B2
(en)
|
2003-05-19 |
2015-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Avian adenoassociated virus and uses thereof
|
|
PL2357189T3
(pl)
|
2003-06-19 |
2017-08-31 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
|
|
WO2005056807A2
(en)
|
2003-12-04 |
2005-06-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Bovine adeno-associated viral (baav) vector and uses thereof
|
|
US20060078542A1
(en)
*
|
2004-02-10 |
2006-04-13 |
Mah Cathryn S |
Gel-based delivery of recombinant adeno-associated virus vectors
|
|
US20060148742A1
(en)
*
|
2004-02-26 |
2006-07-06 |
Kaye David M |
Polynucleotide delivery to cardiac tissue
|
|
US7722596B2
(en)
*
|
2004-02-26 |
2010-05-25 |
Osprey Medical, Inc. |
Regional cardiac tissue treatment
|
|
DK1804839T3
(da)
|
2004-09-22 |
2012-04-10 |
St Jude Childrens Res Hospital |
Forbedret ekspression af faktor ix i genterapivektorer
|
|
AU2005316476A1
(en)
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
|
US8283151B2
(en)
|
2005-04-29 |
2012-10-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
|
|
US8152786B2
(en)
*
|
2006-11-07 |
2012-04-10 |
Osprey Medical, Inc. |
Collection catheter and kit
|
|
US9050400B2
(en)
*
|
2008-08-12 |
2015-06-09 |
Osprey Medical, Inc. |
Remote sensing catheter system and methods
|
|
US20100041984A1
(en)
*
|
2008-08-12 |
2010-02-18 |
James Edward Shapland |
Impedance sensing device and catheter system
|
|
US8889641B2
(en)
|
2009-02-11 |
2014-11-18 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
FR2952374B1
(fr)
*
|
2009-11-06 |
2012-11-16 |
Univ Claude Bernard Lyon |
Production de facteur ix recombinant dans une lignee cellulaire hepatocytaire humaine
|
|
WO2011057243A2
(en)
*
|
2009-11-09 |
2011-05-12 |
University Of Central Florida Research Foundation, Inc. |
Administration of plant expressed oral tolerance agents
|
|
IN2012DN04875A
(OSRAM)
*
|
2009-12-08 |
2015-09-25 |
Health Research Inc |
|
|
US9295816B2
(en)
*
|
2009-12-09 |
2016-03-29 |
Osprey Medical, Inc. |
Catheter with distal and proximal ports
|
|
ES2680915T3
(es)
*
|
2010-01-28 |
2018-09-11 |
The Children's Hospital Of Philadelphia |
Plataforma de fabricación escalable para la purificación de vectores virales y vectores virales purificados de este modo para su utilización en terapia génica
|
|
KR101930711B1
(ko)
|
2010-10-12 |
2018-12-19 |
더 칠드런스 호스피탈 오브 필라델피아 |
혈우병 ｂ의 치료를 위한 방법 및 조성물
|
|
PT2717893T
(pt)
*
|
2011-06-08 |
2019-08-20 |
Translate Bio Inc |
Composições de nanopartículas lipídicas e métodos para transferência de arnm
|
|
WO2012177778A1
(en)
|
2011-06-20 |
2012-12-27 |
Mount Sinai School Of Medicine |
Anti-tnf- therapy for the mucopolysaccharidoses and other lysosomal disorders
|
|
WO2013023126A2
(en)
|
2011-08-11 |
2013-02-14 |
Osprey Medical Inc. |
Systems and methods for limb treatment
|
|
WO2017180807A1
(en)
|
2016-04-15 |
2017-10-19 |
Baxalta Incorporated |
Method and apparatus for providing a pharmacokinetic drug dosing regiment
|
|
AU2014287005C1
(en)
*
|
2013-07-12 |
2021-06-03 |
The Children's Hospital Of Philadelphia |
AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies
|
|
MX392639B
(es)
|
2014-03-21 |
2025-03-24 |
Univ Leland Stanford Junior |
Vectores virales recombinantes para la integración de transgenes
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
WO2017100676A1
(en)
*
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
US10896749B2
(en)
|
2017-01-27 |
2021-01-19 |
Shire Human Genetic Therapies, Inc. |
Drug monitoring tool
|
|
KR102386890B1
(ko)
|
2017-05-22 |
2022-04-15 |
다케다 야쿠힌 고교 가부시키가이샤 |
B형 혈우병 유전자 요법을 위한 증가된 발현을 가지는 재조합 fix 변이체를 암호화하는 바이러스 벡터
|
|
WO2019083171A2
(ko)
|
2017-10-26 |
2019-05-02 |
주식회사 큐로진생명과학 |
솔루블 vegfr-1 변이체 cdna를 함유하는 raav를 포함하는 황반변성 치료용 조성물
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
BR112021007301A2
(pt)
|
2018-10-18 |
2021-07-27 |
Intellia Therapeutics, Inc. |
composições e métodos para expressar fator ix
|